THE APPLICATION OF THE NATIONAL INSTITUTE OF CLINICAL EXCELLENCE GUIDELINES FOR TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN THE UNITED KINGDOM
THE SEXUAL DYSFUNCTION OF LOUIS XVI
Management of prostate cancer in older men
Why do men opt out of prostate-cancer screening? Attitudes and perception among participants and non-participants of a screening trial
Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer
Raman spectral imaging of prostate cancer
Predicting renal functional outcomes after surgery for renal cortical tumours
Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy
Intractable haematuria
The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service
The recovery of urinary continence after radical retropubic prostatectomy
Female sexual dysfunction in urological patients
Visual cues as a surrogate for tactile feedback during robotic-assisted laparoscopic prostatectomy
Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer
Laparoscopic vs open retropubic intrafascial nerve-sparing radical prostatectomy
Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder
Bladder malignancies in children aged <18 years
The sphingosine-1-phosphate pathway is upregulated in response to partial urethral obstruction in male rats and activates RhoA/Rho-kinase signalling
Chronic partial bladder outlet obstruction does not impair erectile function in male rats
Comparative effects of T-type and L-type Ca2+-antagonists against noradrenaline-induced contractions of human vas deferens
THE COST-EFFECTIVENESS OF SOLIFENACIN VS FESOTERODINE, OXYBUTYNIN IMMEDIATE-RELEASE, PROPIVERINE, TOLTERODINE EXTENDED-RELEASE AND TOLTERODINE IMMEDIATE-RELEASE IN THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER IN THE UK NATIONAL HEALTH SERVICE
BENIGN PROSTATIC HYPERPLASIA
Abbreviations
Diary
Levels of Evidence
Treatment of Interstitial Cystitis and Chronic Prostatitis